SMITHTOWN, N.Y., April 24, 2018 (GLOBE NEWSWIRE) iGambit, Inc. (OTCBB: IGMB) is pleased to announce that the company’s wholly owned subsidiary, HealthDatix, has entered into a mutually beneficial relationship with DocsInk. Networking with DocsInk will allow us to integrate and securely share information between our two systems to mutually benefit our shared clients, and streamline our operations.
HealthDatix, Inc. is pleased to announce their engagement with DocsInk, a cloud-based chronic care management (CCM) and team-based communication platform. HealthDatix’s WellDatix Annual Wellness Visit is the perfect precursor for identifying patients qualified for Chronic Care management. HealthDatix has partnered with DocsInk as our technology partner of choice to provide healthcare professionals with a seamless, easy to use integration of both services.
Todays revolutionary healthcare services require a team-based approach, where multiple healthcare providers join together to deliver personalized patient care plans. This value-based model requires purchasing outside services through business affiliations with technology providers in order to provide vastly improved healthcare outcomes for those individual patients.
HealthDatix's Annual Wellness Visit (AWV) solution provides a comprehensive patient care plan that is used by various healthcare providers. Our Annual Wellness Visit allows them to diagnose those patients that possess 2 or more chronic conditions that will last at least a year. The HealthDatix and DocsInk integration will automatically send that individual patients care plan to DocsInk, ensuring a seamless transition into a Chronic Care Management program for the ongoing treatment, and relief of that patient’s conditions.
We expect the integration of the two applications to be completed by the end of 2018 Q2.
In forming relationships with various healthcare providers, a network of extraordinary technology tools is established. That network delivers a sustainable and scalable model for improving healthcare quality, and lowering the overall cost of care.
Healthy, Longer Lives, that’s our mission. Within the population of any group or organization there are people who are healthy and those that are at risk. Our mission is to aggregate their data and deliver accurate reporting necessary to make vital decisions on a course of treatment or education for those at risk. We empower you with the data needed to negotiate future health costs. We’re helping to shape the future of our nation’s health care system, with robust leveraging of technology that delivers value-based healthcare and payment without extra staff or additional efforts on the part of the caregiver. Our proprietary data analytics management uncovers new opportunities for health wellness visits and the passive monitoring of people with chronic conditions. For more information, please visit www.healthdatix.com.
About DocsInk, LLC
DOCSINK is the only HIPAA secure messaging product to meet MACRA and MIPS standard, preparing organizations for the future of healthcare. DocsInk LLC owns and operates a charge capture and mobile healthcare communication platform for single doctors, multi-specialties, hospitals, and ACOs. Its DocsInk platform enables the users to submit bills, notify and activate the transition of care coordinators, and send notices of admission or discharge to the selected primary care or referring providers. The company’s DocsInk comprises a Web-based dashboard and a mobile application for charge capture, texting, discharge notification, telehealth, chronic care management and referral management applications. DocsInk LLC was incorporated in 2012 and is based in Wrightsville Beach, North Carolina. For more information, please visit www.docsink.com.
About iGambit Inc.
iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. We are a company focused on pursuing specific medical strategies and objectives. These objectives have included, among others, the acquisition of medical technology companies with strong growth potential easily recognized in the public arena. For more information, please visit www.igambit.com. Information on our web-site does not comprise a part of this press release.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this document and elsewhere by iGambit are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward- looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. and U.S. government policies and regulations, including, but not limited to those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in iGambit Inc.'s filings with the Securities and Exchange Commission.